I wanted to let everyone know that over the next two weeks my posts might become few and far between. Iaa am traveling with my family in Alaska where my ability to find either internet or cell connections has become difficult. I will attempt to find an occasional connection and put something up. I will [...]
The Early/Expanded Access Committee has informed me that four additional sites have been added to the trial so there are now 23 States that have an expanded access trial of MDV3100 available to men with advanced prostate cancer. The trial is designed to monitor the safety of the drug in men with progressive castration-resistant advanced [...]
When the press discusses medical mistakes they are usually referring to mistakes made in a hospital, but guess what, mistakes are often made in a doctors office. These mistakes are not counted in the statistics often quoted. Twelve year old data from the Institute of Medicine sites the horrific statistic that each year between 44,000 [...]
A new randomized study (FinnProstate Study VII) on the merits of intermittent androgen deprivation (IAD) compared to continuous androgen therapy (CAD) contradicts the recent revelations from the last ASCO presentation (Hussain et.al) where the clear conclusion was that CAD was superior to IAD. At the ASCO conference Dr. Hussain’s study concluded that IAD was significantly [...]
In an updated study published in the New England Journal of Medicine men who had a radical prostatectomy did not enjoy the experience of a reduced all-cause mortality or prostate cancer mortality compared with those men who had only observation through several years of follow-up. The subject men had localized prostate cancer often detected by [...]
Men with locally advanced prostate cancer have a better survival chance if they receive radiotherapy along with androgen deprivation therapy (ADT). This data was presented at the recent American Society of Clinical Oncology (ASCO) 2012 conference. Professor Malcom Mason from Whales University discussed a trial he conducted that demonstrated that for a man diagnosed with [...]
I received a very disturbing notice from Cancer Care about their ability to provide financial support for men with cancer, including men with prostate cancer. As of August 6, 2012 they will not be able to accept applications or provide assistance to men with cancer unless they meet the following criteria: 1- Men diagnosed with [...]
Science and good medicine is not always what it seems. We all believe that if something is logical it must be true, but often the most logical assumptions we make do not stand up to good scientific inquiry. Many of us choke on the fact that Provenge extends life while it has no effect on [...]
In a study conducted by Choueiri et al. published in Cancer it was suggested that men who have prostate cancer that was treated by a radical prostatectomy (RP) who then had a long time to a biochemical recurrence (BCR) or a long PSA doubling time after a BCR have no higher overall risk of death [...]
According to an article published in URO Today the belief that adjuvant androgen suppression therapy (AST) is associated with early deaths due to myocardial infarctions (MCIs) is not true. The belief that ASTs increases deaths from MCIs comes from the TROG 96.01 trial conclusions. Now there has been a retrospective, long term (ten year) meta-analysis [...]
